ReviewFrontiers in medicine2021

Combination of Angiotensin (1-7) Agonists and Convalescent Plasma as a New Strategy to Overcome Angiotensin Converting Enzyme 2 (ACE2) Inhibition for the Treatment of COVID-19.

Hawraa Issa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.